Maria Alriksson Email

CEO . Abera Bioscience AB

Current Roles

Employees:
15
Revenue:
$2.3M
About
Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide.\n\nAbera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.
Abera Bioscience AB Address

Uppsala, null
SE
Abera Bioscience AB Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.